Tag Archives: late gadolinium enhancement

Introduction Cardiac sarcoidosis (CS) is associated with increased morbidity and mortality.1 Thus, early diagnosis is crucial to introducing immunosuppressive therapy that could prevent an adverse outcome.2 This focused review will discuss the pathology of CS, when to suspect and evaluate CS, and highlight the roles of advanced imaging modalities, i.e. cardiac magnetic resonance imaging (MRI) and positron emission tomography (PET) with 18F-Fluorodeoxyglucose/computed tomography (CT) scan (18F-FDG-PET/CT), and their diagnostic and prognostic values in CS in the current content of guidelines for the diagnostic workflow of CS.3 Epidemiology and

The right ventricle ‘A walk around the heart’ was the title of the recent British Society of Heart Failure (BSH) day for training and revalidation. After passing through the left atrium and ventricle on our walk, we stopped at the right ventricle (RV). Our tour guide at this juncture was Professor Andrew Clark (Chair of Academic Cardiology, Hull York Medical School, and BSH President). The causes of RV dysfunction were outlined initially. These can broadly be divided into left heart disease (ischaemia, cardiomyopathy, valve disease), RV failure (as for left heart), pulmonary hypertension (pulmonary artery hypertension [PAH], thromboemboli